Treatment course and follow-up
With the final diagnosis of PCL, the patient was started on the
bortezomib, lenalidomide, dexamethasone (VRD) regimen. The patient was
responding to the treatment. but unfortunately, after the third cycle of
chemotherapy, the patient developed severe sepsis and passed away.